Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 30 results.
User Information
Export Records
  1. 1.   Renal, hepatic, pulmonary and adrenal tumors induced by prenatal inorganic arsenic followed by dimethylarsinic acid in adulthood in CD1 mice
  2. Tokar, E. J.; Diwan, B. A.; Waalkes, M. P.
  3. Toxicology Letters. 2012, Mar; 209(2): 179-185.
  1. 2.   Nitric oxide donor, V-PROLI/NO, provides protection against arsenical induced toxicity in rat liver cells: Requirement for Cyp1a1
  2. Qu, W.; Cheng, L. D.; Dill, A. L.; Saavedra, J. E.; Hong, S. Y.; Keefer, L. K.; Waalkes, M. P.
  3. Chemico-Biological Interactions. 2011, Aug; 193(1): 88-96.
  1. 3.   Carcinogenic Effects of "Whole-Life" Exposure to Inorganic Arsenic in CD1 Mice
  2. Tokar, E. J.; Diwan, B. A.; Ward, J. M.; Delker, D. A.; Waalkes, M. P.
  3. Toxicological Sciences. 2011, Jan; 119(1): 73-83.
  1. 4.   A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo
  2. Hancock, C. N.; Stockwin, L. H.; Han, B. N.; Divelbiss, R. D.; Jun, J. H.; Malhotra, S. V.; Hollingshead, M. G.; Newton, D. L.
  3. Free Radical Biology and Medicine. 2011, Jan; 50(1): 110-121.
  1. 6.   Transcriptional up-regulation of SOD1 by CEBPD: A potential target for cisplatin resistant human urothelial carcinoma cells
  2. Hour, T. C.; Lai, Y. L.; Kuan, C. I.; Chou, C. K.; Wang, J. M.; Tu, H. Y.; Hu, H. T.; Lin, C. S.; Wu, W. J.; Pu, Y. S.; Sterneck, E.; Huang, A. M.
  3. Biochemical Pharmacology. 2010, Aug; 80(3): 325-334.
  1. 7.   Arsenic Exposure In Utero and Nonepidermal Proliferative Response in Adulthood in Tg.AC Mice
  2. Tokar, E. J.; Diwan, B. A.; Waalkes, M. P.
  3. International Journal of Toxicology. 2010, May; 29(3): 291-296.
  1. 8.   Arsenic Exposure Transforms Human Epithelial Stem/Progenitor Cells into a Cancer Stem-like Phenotype
  2. Tokar, E. J.; Diwan, S. A.; Waalkes, M. P.
  3. Environmental Health Perspectives. 2010, Jan; 118(1): 108-115.
  1. 9.   Fetal arsenic exposure appears to facilitate endocrine disruption by postnatal diethylstilbestrol in neonatal mouse adrenal
  2. Liu, J.; Yu, L. M.; Coppin, J. F.; Tokar, E. J.; Diwan, B. A.; Waalkes, M. P.
  3. Chemico-Biological Interactions. 2009 182(2-3): 253-258.
  1. 10.   Arsenic-induced malignant transformation of human keratinocytes: Involvement of Nrf2
  2. Pi, J. B.; Diwan, B. A.; Sun, Y.; Liu, J.; Qu, W.; He, Y. Y.; Styblo, M.; Waalkes, M. P.
  3. Free Radical Biology and Medicine. 2008 45(5): 651-658.
  1. 11.   The nitric oxide prodrug, V-PYRRO/NO, mitigates arsenic-induced liver cell toxicity and apoptosis
  2. Qu, W.; Liu, J.; Fuquay, R.; Saavedra, J. E.; Keefer, L. K.; Waalkes, M. P.
  3. Cancer Letters. 2007, Oct; 256(2): 238-245.
  1. 12.   Transplacental arsenic carcinogenesis in mice
  2. Waalkes, M. P.; Liu, J.; Diwan, B. A.
  3. Toxicology and Applied Pharmacology. 2007, Aug; 222(3): 271-280.
  1. 13.   Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic
  2. Xie, Y. X.; Liu, J.; Benbrahim-Tallaa, L.; Ward, J. M.; Logsdon, D.; Diwan, B. A.; Waalkes, M. P.
  3. Toxicology. 2007, Jul; 236(1-2): 7-15.
  1. 14.   Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism
  2. Liu, J.; Xie, Y. X.; Cooper, R.; Duchanne, D. M. K.; Tennant, R.; Diwan, B. A.; Waalkes, M. P.
  3. Toxicology and Applied Pharmacology. 2007, May; 220(3): 284-291.
  1. 15.   Arsenicals in maternal and fetal mouse tissues after gestational exposure to arsenite
  2. Devesa, V.; Adair, B. M.; Liu, J.; Waalkes, M. P.; Diwan, B. A.; Styblo, M.; Thomas, D. J.
  3. Toxicology. 2006, Jul; 224(1-2): 147-155.
  1. 16.   Transplacental arsenic plus postnatal 12-O-teradecanoyl phorbol-13-acetate exposures associated with hepatocarcinogenesis induce similar aberrant gene expression patterns in male and female mouse liver
  2. Liu, J.; Xie, Y. X.; Merrick, B. A.; Shen, J.; Ducharme, D. M. K.; Collins, J.; Diwan, B. A.; Logsdon, D.; Waalkes, M. P.
  3. Toxicology and Applied Pharmacology. 2006, Jun; 213(3): 216-223.
  1. 17.   Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure
  2. Liu, J.; Xie, Y. X.; Ducharme, D. M. K.; Shen, J.; Diwan, B. A.; Merrick, B. A.; Grissom, S. F.; Tucker, C. J.; Paules, R. S.; Tennant, R.; Waalkes, M. P.
  3. Environmental Health Perspectives. 2006, MAR; 114(3): 404-411.
  1. 18.   Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment
  2. Waalkes, M. P.; Liu, J.; Ward, J. M.; Powell, D. A.; Diwan, B. A.
  3. Cancer Research. 2006, FEB 1; 66(3): 1337-1345.
  1. 19.   Low level, long-term inorganic arsenite exposure causes generalized resistance to apoptosis in cultured human keratinocytes: Potential role in skin co-carcinogenesis
  2. Pi, J. B.; He, Y. Y.; Bortner, C.; Huang, J. L.; Liu, J.; Zhou, T.; Qu, W.; North, S. L.; Kasprzak, K. S.; Diwan, B. A.; Chignell, C. F.; Waalkes, M. P.
  3. International Journal of Cancer. 2005, AUG 10; 116(1): 20-26.
  1. 20.   All-trans-retinoic acid (ATRA) and arsenic trioxide-induced expression and regulation of programmed cell death 4 (PDCD4) in acute promyelocytic leukemia
  2. Ozpolat, B.; Tirado-Gomez, M.; Colburn, N. H.; Berestein, G. L.
  3. Blood. 2004, NOV 16; 104(11, Part 1, Abstract 886): 253A-253A.
  1. 21.   Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic
  2. Liu, J.; Xie, Y. X.; Ward, J. M.; Diwan, B. A.; Waalkes, M. P.
  3. Toxicological Sciences. 2004 77(2): 249-257.
  1. 22.   Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero
  2. Waalkes, M. P.; Liu, J.; Chen, H.; Xie, Y. X.; Achanzar, W. E.; Zhou, Y. S.; Cheng, M. L.; Diwan, B. A.
  3. Journal of the National Cancer Institute. 2004 96(6): 466-474.
  1. 23.   Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation
  2. Waalkes, M. P.; Liu, J.; Ward, J. M.; Diwan, L. A.
  3. Toxicology. 2004 198(1-3): 31-38.
  1. 24.   Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation
  2. Liu, J.; Li, C. X.; Qu, W.; Leslie, E.; Bonifant, C. L.; Buzard, G. S.; Saavedra, J. E.; Keefer, L. K.; Waalkes, M. P.
  3. Molecular Cancer Therapeutics. 2004 3(6): 709-714.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel